Abstract

The α-aminoamide family of sodium ion channel blockers have exhibited analgesic effects on neuropathic pain. Here, a series of novel α-aminoamides containing an indole ring were designed and synthesized. These compounds were evaluated in mice using a formalin test and they exhibited significant anti-allodynia activities. However, the analgesic mechanism of these compounds remains unclear; a subset of the synthesized compounds can only moderately inhibit the sodium ion channel, Nav1.7, in a whole-cell patch clamp assay. Overall, these results suggest that introduction of an indole moiety to α-aminoamide derivatives can significantly improve their bioactivity and further study is warranted.

Highlights

  • Neuropathic pain is a chronic disease caused by lesion or dysfunction of the somatosensory system [1,2]

  • Recent studies have suggested that voltage-gated sodium channels (VGSCs) may be an ideal therapeutic target for neuropathic pain

  • Such slight chemical structural differences between ralfinamide and safinamide result in dramatic changes in pharmacological activity, indicating that delicate structure-activity relationship (SAR) inspection is needed for these types of compounds

Read more

Summary

Introduction

Neuropathic pain is a chronic disease caused by lesion or dysfunction of the somatosensory system [1,2]. Some α-aminoamide derivatives, including ralfinamide (Figure 1), are potential anti-neuropathic drug candidates. Data from animal models of inflammatory and neuropathic pain have suggested that ralfinamide exhibits a significant analgesic effect while having a well-tolerated safety profile [6,7,8]. Ralfinamide is the only small molecule drug in a late-stage clinical trial for the treatment of neuropathic pain [9,10,11,12,13]. The only structural difference between ralfinamide and safinamide is the position of the fluoro substituent (Figure 1). Such slight chemical structural differences between ralfinamide and safinamide result in dramatic changes in pharmacological activity, indicating that delicate structure-activity relationship (SAR) inspection is needed for these types of compounds.

Chemical
Synthesis
Analgesic of Target
Inhibitory
Thein compounds were screened a single dose ofthe
General Information
Chemistry
Preparation of Intermediates 4a–d
Preparation of Intermediates 5a–d
Preparation of Target Compounds 6a–d
Preparation of Target Compounds 7a–d
Formalin Test
Electrophysiology
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call